jump to navigation

NovaThera and Gamida Cell collaborate to develop cell therapeutics for lung disease May 11, 2007

Posted by israelhealthcare in Cell Therapeutics.
Tags: ,
add a comment

NovaThera and Gamida Cell signed a collaboration agreement aimed at developing cell therapeutic treatments for lung repair and regeneration. The two companies will pool technology and expertise and work together with the clinical team at Papworth Hospital in the UK towards advancing cell therapy approaches for treating lung disease.

NovaThera specializes in pioneering applications of biomaterials and stem cell biology for regenerative medicine and tissue engineering to provide innovative therapeutic solutions.

Gamida Cell develops therapeutics using proprietary technologies that expand populations of hematopoietic stem/progenitor cells such as those derived from cord blood for the treatment of hematological diseases as well as for tissue regeneration applications.

“This is a very exciting development, and could be a huge step towards a practical approach to the regeneration and repair of lungs severely damaged by incurable diseases such as emphysema and smoking,” said Dame Professor Julia Polak, from the Imperial College London and a world expert in the field of lung pathology.

Lung disease is a major killer and the cause of chronic illness in the western world. Research indicates that considerable advances in treating lung disease could come from using stem cells to repair and regenerate damaged tissues.

Sponsored Links – Medical Application Testing Management Software | Natural Skin Care Products | Home ECG Monitoring Device

Advertisements